29 Programs

  • Current and Future Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia

    Explore program
  • Optimal Management of Squamous Cell Carcinoma of the Anal Canal

    Explore program
  • Novel Investigational Antibody-Drug Conjugates for Ovarian Cancer

    Explore program
    • February 2026 1.25 ABIM MOC, ABS MOC, CME 54min
      • K
      Dr Moore
    • February 2026 0.75 ABIM MOC, ABS MOC, CME 36min
      • K
      Dr Moore
  • The New Understanding of Toxicities Associated with Chimeric Antigen Receptor (CAR) T-Cell Therapy

    Explore program